Analyst Group's Comment on STENOCARE Launching Next Generation Medical Cannabis Oil Product in Australia

STENOCARE announced on May 23rd that the company’s premium product, the Astrum oil, is ready for launch on the Australian market. The product is expected to have several benefits compared to the medical cannabis oil available today, including a higher, more uniform, and faster uptake in the blood. The first product, Astrum 10-10 oil Stenocare, with 10 mg/ml THC and 10 mg/ml CBD, are expected to be available for patients in Australia from the summer of 2024, six months ahead of schedule.

Länk till analysen i sin helhet: https://analystgroup.se/kommentarer/comment-on-stenocare-launching-next-generation-medical-cannabis-oil-product-in-australia/